GlaxoSmithKline Pharmaceuticals informs about closure of trading window

23 Dec 2025 Evaluate

In terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, GlaxoSmithKline Pharmaceuticals has informed that the trading period for buying or selling of Company's shares is closed from Thursday, 1st January 2026 till 48 hours after the announcement/declaration of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2025. The date of Board Meeting for declaration of the Unaudited Financial Results of the Company for the quarter & nine months ended 31st December 2025 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2379.85 105.80 (4.65%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×